CMC in the Therapeutic Development Process with Olga Paley of Takeda

Feb

2025

11:00 am – 12:00 pm

In Person (view details)

Featured Speaker(s): Olga Paley

Cost: Free

Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.

Texas Biologics website

Description

Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, Manufacturing and Controls (CMC) part of the therapeutic development process. Paley is a UT alum, earning her Chemical Engineering Ph.D. in 2014.

This talk is part of a continuing series from Texas Biologics covering cutting-edge technology developments across a range of research fields.